BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $6.3M of Biomea Fusion, Inc.
10% owner
Sold$6,250,000
$31.25Price
200,000Shares
−5%Stake
What BMEA did after the filing
- The stock from Mon, Apr 10 open, $25.73
- +22.9%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the May 22 close.
Traded Fri, Mar 31. Filed Thu, Apr 6. Returns use the Apr 10 open and the May 22 close. Not investment advice.